scholarly journals Inhibitory Effects of Tannins on the NADH Dehydrogenase Activity of Bovine Heart Mitochondrial Complex I.

1999 ◽  
Vol 22 (3) ◽  
pp. 240-243 ◽  
Author(s):  
Kiyoshi KONISHI ◽  
Takashi TANAKA
ChemInform ◽  
2005 ◽  
Vol 36 (12) ◽  
Author(s):  
Hidefumi Makabe ◽  
Yasunao Hattori ◽  
Yuka Kimura ◽  
Hiroyuki Konno ◽  
Masato Abe ◽  
...  

2003 ◽  
Vol 13 (22) ◽  
pp. 4101-4105 ◽  
Author(s):  
José R Tormo ◽  
Teresa Gallardo ◽  
Eva Peris ◽  
Almudena Bermejo ◽  
Nuria Cabedo ◽  
...  

eLife ◽  
2014 ◽  
Vol 3 ◽  
Author(s):  
William W Wheaton ◽  
Samuel E Weinberg ◽  
Robert B Hamanaka ◽  
Saul Soberanes ◽  
Lucas B Sullivan ◽  
...  

Recent epidemiological and laboratory-based studies suggest that the anti-diabetic drug metformin prevents cancer progression. How metformin diminishes tumor growth is not fully understood. In this study, we report that in human cancer cells, metformin inhibits mitochondrial complex I (NADH dehydrogenase) activity and cellular respiration. Metformin inhibited cellular proliferation in the presence of glucose, but induced cell death upon glucose deprivation, indicating that cancer cells rely exclusively on glycolysis for survival in the presence of metformin. Metformin also reduced hypoxic activation of hypoxia-inducible factor 1 (HIF-1). All of these effects of metformin were reversed when the metformin-resistant Saccharomyces cerevisiae NADH dehydrogenase NDI1 was overexpressed. In vivo, the administration of metformin to mice inhibited the growth of control human cancer cells but not those expressing NDI1. Thus, we have demonstrated that metformin's inhibitory effects on cancer progression are cancer cell autonomous and depend on its ability to inhibit mitochondrial complex I.


Tetrahedron ◽  
2008 ◽  
Vol 64 (33) ◽  
pp. 7695-7703 ◽  
Author(s):  
Shin-ichi Furuhata ◽  
Yasunao Hattori ◽  
Motonori Okajima ◽  
Hiroyuki Konno ◽  
Masato Abe ◽  
...  

2000 ◽  
Vol 55 (7-8) ◽  
pp. 620-630 ◽  
Author(s):  
Gerhard Bringmann ◽  
Doris Feineis ◽  
Ralf God ◽  
Ralph Brückner ◽  
Jens Achim-Protzen ◽  
...  

Abstract Several N-alkanoyl derivatives (4-9 and 13-16) of the potent mitochondrial complex I inhibitor TaClo (1-trichlorom ethyl-1,2,3,4-tetrahydro-β-carboline, 2) have been synthesized in order to elucidate the role of hydrophobic portion in the inhibitory action. Using rat brain homogenates or submitochondrial particles, the inhibitory effects of these compounds towards NADH-ubiquinone reductase (complex I) activity indeed appeared to correlate quite strongly with their lipophilic character. An X-ray structure analysis, exemplarily performed for N-acetyl-TaClo (4), revealed the N-substituent of such chlorinated agents to be dramatically pushed out of the β-carboline ring ‘plane’ due to the high steric demand of the huge trichloromethyl group at C-1.


Sign in / Sign up

Export Citation Format

Share Document